Literature DB >> 3349075

Photoaffinity labelling of a 150 kDa (Na + K + Cl)-cotransport protein from duck red cells with an analog of bumetanide.

M Haas1, B Forbush.   

Abstract

We have used a radiolabelled, benzophenone analog of bumetanide, 4-[3H]benzoyl-5-sulfamoyl-3-(3-thenyloxy)benzoic acid ([3H]BSTBA) to photolabel plasma membranes from duck red blood cells. BSTBA, like bumetanide, is a loop diuretic and a potent inhibitor of (Na + K + Cl) cotransport, and [3H]BSTBA binds to intact duck red cells with a high affinity similar to that of [3H]bumetanide (K 1/2 congruent to 0.1 microM). We incubated duck red cells with [3H]BSTBA, then lysed the cells and exposed the ghosts to ultraviolet light. The ghosting and photolysis was done at 0 degree C to prevent dissociation of the [3H]BSTBA. The ghosts were then sonicated to remove the nuclei and run on SDS-polyacrylamide gels. Analysis of H2O2-digested gel slices revealed [3H]BSTBA to be incorporated into a protein of approx. 150 kDa. This is the same molecular weight we obtain for a protein from dog kidney membranes which is photolabelled by [3H]BSTBA in a manner highly consistent with labelling of the (Na + K + Cl) cotransporter (Haas and Forbush (1987) Am. J. Physiol. 253, C243-C252). Several lines of evidence strongly suggest that the 150 kDa protein from duck red cell membranes is an integral component of the (Na + K + Cl)-cotransport system in these cells: (1) Photolabelling of this protein by [3H]BSTBA is blocked when 10 microM unlabelled bumetanide is included in the initial incubation medium with [3H]BSTBA; (2) Photoincorporation of [3H]BSTBA into the 150 kDa protein is markedly increased when the initial incubation medium is hypertonic or contains norepinephrine, conditions which similarly stimulate both (Na + K + Cl) cotransport and saturable [3H]bumetanide binding in duck red cells; (3) The photolabelling of this protein shows a saturable dependence on [3H]BSTBA concentration, with a K1/2 (0.06 microM) similar to that for the reversible, saturable binding of [3H]BSTBA and [3H]bumetanide to duck red cells; and (4) [3H]BSTBA photoincorporation into the 150 kDa protein, like saturable [3H]bumetanide binding to intact cells, requires the simultaneous presence of Na+, K+, and Cl- in the medium containing the radiolabelled diuretic.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3349075     DOI: 10.1016/0005-2736(88)90054-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Role of phospholipids in the binding of bumetanide to the rabbit parotid Na/K/Cl cotransporter.

Authors:  A Corcelli; R J Turner
Journal:  J Membr Biol       Date:  1991-03       Impact factor: 1.843

2.  Inhibition of Na-K-C1 cotransport in Ehrlich ascites cells by antiserum against purified proteins of the cotransporter.

Authors:  P B Dunham; F Jessen; E K Hoffmann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Ionic effects on bumetanide binding to the activated Na/K/2Cl cotransporter: selectivity and kinetic properties of ion binding sites.

Authors:  R S Hegde; H C Palfrey
Journal:  J Membr Biol       Date:  1992-02       Impact factor: 1.843

4.  Identification, characterization and purification of a 160 kD bumetanide-binding glycoprotein from the rabbit parotid.

Authors:  S J Reshkin; S I Lee; J N George; R J Turner
Journal:  J Membr Biol       Date:  1993-11       Impact factor: 1.843

5.  Purification of proteins of the Na/Cl cotransporter from membranes of Ehrlich ascites cells using a bumetanide-sepharose affinity column.

Authors:  P W Feit; E K Hoffmann; M Schiødt; P Kristensen; F Jessen; P B Dunham
Journal:  J Membr Biol       Date:  1988-07       Impact factor: 1.843

6.  Solubilization and partial purification of the rabbit parotid Na/K/Cl-dependent bumetanide binding site.

Authors:  R J Turner; J N George
Journal:  J Membr Biol       Date:  1990-02       Impact factor: 1.843

7.  Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant gram-positive bacteria.

Authors:  Alexey Ruzin; Guy Singh; Anatoly Severin; Youjun Yang; Russell G Dushin; Alan G Sutherland; Albert Minnick; Michael Greenstein; Michael K May; David M Shlaes; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.